ProfileGDS4718 / 214191_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 48% 50% 42% 52% 44% 45% 51% 53% 52% 52% 48% 48% 50% 43% 49% 55% 47% 42% 53% 54% 58% 45% 47% 47% 46% 50% 50% 61% 52% 45% 45% 48% 47% 52% 50% 48% 51% 50% 49% 43% 49% 48% 50% 48% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.3885648
GSM549102patient 115, normal, homogenized [OPG study]5.5154650
GSM549104patient 119, normal, homogenized [OPG study]5.0976642
GSM549108patient 138, normal, homogenized [OPG study]5.6427852
GSM549119patient 077, normal, homogenized [OPG study]5.2270644
GSM549133patient 032, cancer, homogenized [OPG study]5.1799645
GSM549139patient 042, cancer, homogenized [OPG study]5.530151
GSM549099patient 107, normal, homogenized [OPG study]5.6735153
GSM549109patient 139, normal, homogenized [OPG study]5.6758952
GSM549110patient 046, normal, homogenized [OPG study]5.6541352
GSM549114patient 063, normal, homogenized [OPG study]5.355848
GSM549122patient 082, normal, homogenized [OPG study]5.4150948
GSM549134patient 033, cancer, homogenized [OPG study]5.4655650
GSM549136patient 036, cancer, homogenized [OPG study]5.0865143
GSM549140patient 044, cancer, homogenized [OPG study]5.4182949
GSM549111patient 047, normal, homogenized [OPG study]5.7877955
GSM549113patient 057, normal, homogenized [OPG study]5.2995647
GSM549132patient 031, cancer, homogenized [OPG study]5.0932742
GSM549137patient 038, cancer, homogenized [OPG study]5.6770753
GSM549142patient 047, cancer, homogenized [OPG study]5.8519854
GSM549100patient 110, normal, homogenized [OPG study]5.9641158
GSM549107patient 135, normal, homogenized [OPG study]5.2255445
GSM549115patient 068, normal, homogenized [OPG study]5.2671947
GSM549116patient 072, normal, homogenized [OPG study]5.3186547
GSM549120patient 078, normal, homogenized [OPG study]5.3003346
GSM549131patient 030, cancer, homogenized [OPG study]5.4744550
GSM549118patient 074, normal, homogenized [OPG study]5.5232150
GSM549129patient 027, cancer, homogenized [OPG study]6.2541761
GSM549123patient 088, normal, homogenized [OPG study]5.6268352
GSM549124patient 006, cancer, homogenized [OPG study]5.2608145
GSM549126patient 015, cancer, homogenized [OPG study]5.2445545
GSM549128patient 025, cancer, homogenized [OPG study]5.4160748
GSM549103patient 117, normal, homogenized [OPG study]5.4098347
GSM549117patient 073, normal, homogenized [OPG study]5.5737852
GSM549138patient 041, cancer, homogenized [OPG study]5.5252750
GSM549141patient 045, cancer, homogenized [OPG study]5.3869948
GSM549130patient 028, cancer, homogenized [OPG study]5.5739351
GSM549101patient 111, normal, homogenized [OPG study]5.5227150
GSM549105patient 128, normal, homogenized [OPG study]5.4950149
GSM549106patient 134, normal, homogenized [OPG study]5.0784143
GSM549112patient 048, normal, homogenized [OPG study]5.4232849
GSM549125patient 011, cancer, homogenized [OPG study]5.3877348
GSM549127patient 024, cancer, homogenized [OPG study]5.5389950
GSM549135patient 035, cancer, homogenized [OPG study]5.360848